Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1956 1
1958 2
1959 1
1961 1
1962 4
1963 1
1964 8
1965 4
1966 8
1967 10
1968 7
1969 6
1970 5
1971 7
1972 6
1973 3
1974 2
1975 6
1976 7
1977 2
1978 7
1979 10
1980 8
1981 9
1982 10
1983 20
1984 13
1985 32
1986 39
1987 34
1988 27
1989 33
1990 28
1991 21
1992 34
1993 21
1994 29
1995 23
1996 42
1997 40
1998 36
1999 62
2000 87
2001 70
2002 81
2003 84
2004 81
2005 76
2006 87
2007 85
2008 98
2009 86
2010 117
2011 124
2012 140
2013 163
2014 170
2015 139
2016 146
2017 157
2018 148
2019 155
2020 78
Text availability
Article attribute
Article type
Publication date

Search Results

2,792 results
Results by year
Filters applied: . Clear all
Page 1
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M, Suzuki R, Oguchi M. Yamaguchi M, et al. Among authors: Suzuki R. Blood. 2018 Jun 7;131(23):2528-2540. doi: 10.1182/blood-2017-12-791418. Epub 2018 Mar 30. Blood. 2018. PMID: 29602763 Review.
NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R. Suzuki R. Curr Hematol Malig Rep. 2018 Feb;13(1):7-12. doi: 10.1007/s11899-018-0430-5. Curr Hematol Malig Rep. 2018. PMID: 29368155 Review.
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K. Iwamoto M, et al. Among authors: Suzuki R. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8487-8492. doi: 10.1073/pnas.1811064116. Epub 2019 Apr 5. Proc Natl Acad Sci U S A. 2019. PMID: 30952782 Free PMC article.
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
Sato-Kaneko F, Yao S, Ahmadi A, Zhang SS, Hosoya T, Kaneda MM, Varner JA, Pu M, Messer KS, Guiducci C, Coffman RL, Kitaura K, Matsutani T, Suzuki R, Carson DA, Hayashi T, Cohen EE. Sato-Kaneko F, et al. Among authors: Suzuki R. JCI Insight. 2017 Sep 21;2(18):e93397. doi: 10.1172/jci.insight.93397. eCollection 2017 Sep 21. JCI Insight. 2017. PMID: 28931759 Free PMC article.
Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated myotube formation.
Tsuchiya M, Hara Y, Okuda M, Itoh K, Nishioka R, Shiomi A, Nagao K, Mori M, Mori Y, Ikenouchi J, Suzuki R, Tanaka M, Ohwada T, Aoki J, Kanagawa M, Toda T, Nagata Y, Matsuda R, Takayama Y, Tominaga M, Umeda M. Tsuchiya M, et al. Among authors: Suzuki R. Nat Commun. 2018 May 24;9(1):2049. doi: 10.1038/s41467-018-04436-w. Nat Commun. 2018. PMID: 29799007 Free PMC article.
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN. Kharfan-Dabaja MA, et al. Among authors: Suzuki R. Biol Blood Marrow Transplant. 2017 Nov;23(11):1826-1838. doi: 10.1016/j.bbmt.2017.07.027. Epub 2017 Aug 7. Biol Blood Marrow Transplant. 2017. PMID: 28797780 Free article.
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators. Kizaki M, et al. Among authors: Suzuki R. Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14. Int J Hematol. 2019. PMID: 30762219 Clinical Trial.
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S, Yadav B, Kuusanmäki H, Malani D, Andersson EI, Pietarinen P, Saikko L, Kovanen PE, Ojala T, Lee DA, Loughran TP Jr, Nakazawa H, Suzumiya J, Suzuki R, Ko YH, Kim WS, Chuang SS, Aittokallio T, Chan WC, Ohshima K, Ishida F, Mustjoki S. Dufva O, et al. Among authors: Suzuki R. Nat Commun. 2018 Apr 19;9(1):1567. doi: 10.1038/s41467-018-03987-2. Nat Commun. 2018. PMID: 29674644 Free PMC article.
ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients.
Sibon D, Nguyen DP, Schmitz N, Suzuki R, Feldman AL, Gressin R, Lamant L, Weisenburger DD, Rosenwald A, Nakamura S, Ziepert M, Maurer MJ, Bast M, Armitage JO, Vose JM, Tilly H, Jais JP, Savage KJ. Sibon D, et al. Among authors: Suzuki R. Haematologica. 2019 Dec;104(12):e562-e565. doi: 10.3324/haematol.2018.213512. Epub 2019 Apr 19. Haematologica. 2019. PMID: 31004022 Free PMC article. No abstract available.
The RNA Methyltransferase Complex of WTAP, METTL3, and METTL14 Regulates Mitotic Clonal Expansion in Adipogenesis.
Kobayashi M, Ohsugi M, Sasako T, Awazawa M, Umehara T, Iwane A, Kobayashi N, Okazaki Y, Kubota N, Suzuki R, Waki H, Horiuchi K, Hamakubo T, Kodama T, Aoe S, Tobe K, Kadowaki T, Ueki K. Kobayashi M, et al. Among authors: Suzuki R. Mol Cell Biol. 2018 Jul 30;38(16):e00116-18. doi: 10.1128/MCB.00116-18. Print 2018 Aug 15. Mol Cell Biol. 2018. PMID: 29866655 Free PMC article.
2,792 results
Jump to page
Feedback